We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Madison Square Garden
MSGS
$9.42B
| $3.63M | 0.01% |
60,079
+295
| +0.5% | +$16.2K |
|
1027
Norwegian Cruise Line
NCLH
$9.38B
| $3.63M | 0.01% |
67,133
+2,300
| +4% | +$110K |
|
|
DGI
1028
DELISTED
DigitalGlobe Inc.
DGI
| $3.62M | 0.01% |
106,380
+1,485
| +1% | +$46.4K |
|
|
ANN
1029
DELISTED
ANN INC
ANN
| $3.62M | 0.01% |
88,231
+9,670
| +12% | +$354K |
|
1030
TD Synnex
SNX
$20.8B
| $3.61M | 0.01% |
93,434
+1,240
| +1% | +$47.7K |
|
1031
Guidewire Software
GWRE
$13.3B
| $3.6M | 0.01% |
68,465
+11,665
| +21% | +$604K |
|
|
KS
1032
DELISTED
KapStone Paper and Pack Corp.
KS
| $3.6M | 0.01% |
109,495
+12,800
| +13% | +$407K |
|
1033
Huntsman Corp
HUN
$1.79B
| $3.59M | 0.01% |
162,010
+2,960
| +2% | +$66.1K |
|
1034
Darling Ingredients
DAR
$9.36B
| $3.58M | 0.01% |
255,679
+7,920
| +3% | +$130K |
|
|
CRC
1035
DELISTED
California Resources Corporation
CRC
| $3.58M | 0.01% |
47,072
+3,239
| +7% | +$198K |
|
1036
National Health Investors
NHI
$3.62B
| $3.58M | 0.01% |
50,427
+3,090
| +7% | +$223K |
|
|
WP
1037
DELISTED
Worldpay, Inc.
WP
| $3.57M | 0.01% |
94,693
+2,550
| +3% | +$92.3K |
|
1038
Ryman Hospitality Properties
RHP
$8.18B
| $3.57M | 0.01% |
58,584
+4,305
| +8% | +$250K |
|
1039
InterDigital
IDCC
$8.4B
| $3.57M | 0.01% |
70,294
+6,115
| +10% | +$317K |
|
1040
Saic
SAIC
$5.1B
| $3.56M | 0.01% |
69,226
+7,175
| +12% | +$375K |
|
1041
Erie Indemnity
ERIE
$12.9B
| $3.55M | 0.01% |
40,633
-16,000
| -28% | -$1.42M |
|
1042
LXP Industrial Trust
LXP
$3.58B
| $3.55M | 0.01% |
72,140
+3,560
| +5% | +$193K |
|
1043
CACI
CACI
$11.5B
| $3.54M | 0.01% |
39,366
+170
| +0.4% | +$14.8K |
|
1044
Pacira BioSciences
PCRX
$1,000M
| $3.54M | 0.01% |
39,783
+6,340
| +19% | +$643K |
|
|
CAB
1045
DELISTED
Cabela's Inc
CAB
| $3.53M | 0.01% |
63,029
+4,100
| +7% | +$227K |
|
1046
Neurocrine Biosciences
NBIX
$16.7B
| $3.52M | 0.01% |
88,670
+20,330
| +30% | +$727K |
|
1047
Kennametal
KMT
$2.67B
| $3.5M | 0.01% |
103,966
+5,843
| +6% | +$197K |
|
1048
FNB Corp
FNB
$6.88B
| $3.5M | 0.01% |
266,257
+4,770
| +2% | +$60.8K |
|
1049
Owens Corning
OC
$12.6B
| $3.5M | 0.01% |
80,551
-204
| -0.3% | -$8.09K |
|
1050
Archrock
AROC
$5.95B
| $3.5M | 0.01% |
104,108
+1,540
| +2% | +$46.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.